Turning Point: The United States Food and Drug Administration gave full approval to an Alzheimer's drug for the first time in two decades.
Why, despite billions of dollars being invested in cancer research annually, is a cure for patients with advanced cancer still an exception rather than a standard?
[
add
]
[
|
|
...
]